Aegerion Pharmaceuticals Announces Presentation at Leerink Global Healthcare Conference

GlobeNewswire

CAMBRIDGE, Mass., Feb. 6, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, announced today that the company will participate in the Leerink 2014 Global Healthcare Conference in New York City. Marc Beer, Chief Executive Officer of Aegerion, is scheduled to present on Wednesday, February 12, 2014 at 1:25 p.m. ET.

The presentation will be webcast live and may be accessed for up to 30 days following the conference by visiting the "Investors" section of Aegerion's website, www.aegerion.com.

About Aegerion Pharmaceuticals

Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. For more information about the company, please visit www.aegerion.com.

Contact:
Aegerion Pharmaceuticals, Inc.
Amanda Murphy
Manager, Investor Relations
857-242-5024
View Comments